These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24614600)

  • 1. Possible role of arginase-1 in concomitant tumor immunity.
    Korrer MJ; Zhang Y; Routes JM
    PLoS One; 2014; 9(3):e91370. PubMed ID: 24614600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D.
    Korrer MJ; Routes JM
    Results Immunol; 2015; 5():1-5. PubMed ID: 25685658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
    Routes JM; Ryan S; Morris K; Takaki R; Cerwenka A; Lanier LL
    J Exp Med; 2005 Dec; 202(11):1477-82. PubMed ID: 16314433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity.
    Miura TA; Cook JL; Potter TA; Ryan S; Routes JM
    J Cell Biochem; 2007 Mar; 100(4):929-40. PubMed ID: 17063489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
    Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
    Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
    Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
    Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
    Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
    Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.
    Tenbusch M; Kuate S; Tippler B; Gerlach N; Schimmer S; Dittmer U; Uberla K
    BMC Immunol; 2008 Apr; 9():13. PubMed ID: 18405363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
    Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
    Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an E1A/E7 chimeric protein sensitizes tumor cells to killing by activated macrophages but not NK cells.
    Miura TA; Li H; Morris K; Ryan S; Hembre K; Cook JL; Routes JM
    J Virol; 2004 May; 78(9):4646-54. PubMed ID: 15078947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
    Kim TS; Chung SW; Kim SH; Kang SN; Kang BY
    Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity.
    Zhang H; Xie Y; Li W; Chibbar R; Xiong S; Xiang J
    Cell Mol Immunol; 2011 Jan; 8(1):23-30. PubMed ID: 21200381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
    Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
    J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
    Kar UK; Jiang J; Champion CI; Salehi S; Srivastava M; Sharma S; Rabizadeh S; Niazi K; Kickhoefer V; Rome LH; Kelly KA
    PLoS One; 2012; 7(7):e38553. PubMed ID: 22808011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen.
    Dudani R; Chapdelaine Y; Faassen Hv Hv; Smith DK; Shen H; Krishnan L; Sad S
    J Immunol; 2002 Jun; 168(11):5737-45. PubMed ID: 12023374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
    Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
    J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells.
    Zhang XY; Liu XG; Wang W; Wang WC; Gao XM
    Immunology; 2003 Apr; 108(4):465-73. PubMed ID: 12667208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.